Introduction Ultrasound-guided percutaneous placement of a suprapubic cystostomy is a common and generally safe procedure in everyday surgery. In case of adverse patient characteristics such as small bladder capacity or high body mass index, however, the procedure carries an increased risk of severe complications, including bowel perforation. The Suprapur® cystostomy set is supposed to enable a safer procedure. The aim of our work was to evaluate the safety and ease of use of the Suprapur® cystostomy set. Material and methods We prospectively evaluated the Suprapur® set in high-risk patients, having either a small bladder capacity below 250 ml or a BMI above 30 kg/m 2 . Complications and surgical outcome were monitored. In addition, patients' contentment and pain during the procedure was assessed with a visual analogue scale (VAS). Possible drawbacks and ease of use were evaluated by customized questionnaires for the operating physician. Results In total, 26 cystostomies were performed by 15 different physicians, 40% (n = 6) of whom were inexperienced first or second year residents. No complications occurred. Mild gross haematuria occurred in 11.5% (n = 4) of cases. Average VAS for pain during and two hours after the procedure was 2.1 (±1.2) and 0.3 (±0.5) respectively. In 91%, (n = 20) of the procedures, the physicians claimed to have felt safe using SUPRAPUR® and more comfortable (82%, n = 18) than with a conventional cystostomy set. Conclusions SUPRAPUR® allows a safe and simple placement of a suprapubic cystostomy even in highrisk patients or in inexperienced hands. It might help to reduce the complications of a common and frequent surgical procedure.
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INTRODUCTION
Percutaneous suprapubic cystostomy (SPC) is a common procedure in urological surgery and is used in a wide range of disorders [1] . It allows drainage of the bladder in case of urinary retention when subvesical obstruction, due to benign prostrate hyperplasia, urethral strictures or phimosis, prevents transurethral catheterization. Furthermore, SPC can be applied as a simple solution for indwelling catheterization in patients with severe incontinence or neurogenic bladder outlet dysfunctions [2, 3, 4] . Generally, SPC is a safe procedure, which can be performed under local anaesthesia and ultrasound-guidance in the majority of cases. After a suprapubic stab incision, a punch trocar is inserted into the bladder, which is used to guide the catheter to its destination [5] . Despite this simple mechanism, placing a SPC harbours a not inconsiderable risk of complications such as bleeding and gross haematuria, infection or malpositioning. The most dreaded complication, however, is perforation of the intestine, observed in around 2.5% of cases [6, 7] . In patients who present additional risk factors such as obesity, small bladder capacity or previous abdominal surgery and radiotherapy, the hazard of severe complications might even be higher.
In 1990, McMullin first described an advanced technique to enable the safe insertion of SPC using the Seldinger technique [8] . The Suprapur ® cystostomy set (REF 3047, Uromed, Oststeinbek, Germany) comprises all components for SPC placement by the respective technique. The aim of our study was to prospectively evaluate the clinical usability and value of Suprapur ® in high-risk patients.
MATERIAL AND METHODS

Patient selection and assessment
The study was approved by the local ethical committee (2014-426-M-MA). We prospectively identified possible high-risk patients, as those who fulfilled one of the study inclusion criteria: BMI >30 kg/m 2 , bladder capacity <250 ml, previous abdominal surgery or radiotherapy. After giving informed consent, the patients underwent SPC by either a urologist or radiologist at our university medical centre. Patient characteristics as well as surgical outcome, such as procedure time or complications using the Clavien classification, were assessed [9] . Bladder capacity was directly measured while filling the bladder via a transurethral catheter (TUC). Customized questionnaires were employed to evaluate the usability of Suprapur ® , as well as patients' contentment. The questionnaire for the operating surgeon contained one question on general convenience: surgeons were asked to assess, on an analogue scale from 1-5, how secure they felt using Suprapur ® in the respective high-risk patients. Three further questions prompted the physician to compare Suprapur ® to standard punch trocar cystostomy sets in terms of feeling of security, usability and time exposure. Using a visual analogue scale (VAS) from 1-10, patients were asked to indicate their pain level during and 2 hours after placement of the SPC. They were also asked to state the level of inconvenience posed by the procedure compared to their expectations.
The Suprapur® set
As shown in Figure 1 , the Suprapur ® set contains a puncture cannula 17.5 GA with a needle length of 18.5 cm, a Lunderquist guidewire (70 cm length) with an insertions guide, two facial dilatators (Ch 10 and Ch 14) and a dilation balloon catheter (Ch 12.5 ml balloon) with a cylindrical tip.
Placement of the suprapubic cystostomy using the Suprapur® set
Prior to the procedure, informed consent to the surgery and the participation in this study was obtained. Microbiological testing of the urine was performed at least 3 days prior to SPC placement and antibiotic therapy was initiated in case of a positive urine culture. If the operating surgeon was a resident, an experienced urologist supervised the procedure. If possible, transurethral catheterization was performed to fill the bladder with saline solution. Local anaesthesia was performed with 10 ml 0.5% scandicain. On patient request, analgosedation with piritramid and midazolam was given. General anaesthesia was performed only in case of severe pain or anxiety. A 17.5 GA cannula was used to puncture the bladder under ultrasound guidance. Advanced imaging with fluoroscopy or computed tomography was employed only in the case of an unfavourable sonographic condition that prohibited safe puncture under ultrasound guidance. After extraction of the core, the guidewire was inserted into the bladder. Subsequent dilation and the insertion of the catheter were carried out via the tensioned guide wire. In the case of haematuria, the catheter was set under gentle traction to compress the access course as described before [5] . After confirmation of correct catheter placement using ultrasound, patients were observed for at least two hours.
RESULTS
Of the 96 possible candidates assessed for SPC placement during the study period, 26 met our inclusion criteria. (±56.0) ml. SPC placement was performed due to obstructive BPH in 38.5% (n = 10) and prostate cancer in 26.9% (n = 7) of the cases. Two patients with obstructive symptoms were suffering from acute prostatitis. Indwelling SPCs were applied due to severe incontinence in 30.7% (n = 8) and neurogenic bladder outlet dysfunction in 3.8% (n = 1) of the cases. Previous abdominal radiotherapy was reported by 15.4% (n = 4) of the patients, while 42.3% (n = 11) had a history of abdominal surgery. In 11.5% (n = 3) of the cases, SPC placement had been performed previously. Aspirin intake was noted in 11.5% (n = 3) of the patients. The procedures were performed by 15 different physicians, of whom 13 were urologists or residents in urology and two were radiologists. As given in Table 2 the majority (73.3%, n = 11) of the surgeons were residents and 40.0% (n = 6) had less than 1 year work experience or had performed fewer than 10 SPC placements, respectively. Only 26.4% (n = 4) of attending physicians had performed more than 30 SPC placements. Surgical outcome is shown in Table 3 . Mean preparation time in the operation theatre was 10.2 (±3.5) minutes and mean procedure time was 9.4 (±4.7) minutes. There was no significant difference between experienced and inexperienced users (p = 0.32). Almost all cases (88.5%, n = 23) were performed under local anaesthesia. Analgosedation was requested by two patients, whereas general anaesthesia was required in one case due to strong pain during bladder filling. Despite the small bladder capacities, ultrasound guidance was sufficient in 77.0% (n = 20) of the SPC placements. In three cases, fluoroscopy or computed tomography were required respectively due to very limited and unfavourable sonographic conditions. In all cases, the first puncture was successful. There was no catheter displacement or any reported complications. In two cases, the balloon of the transurethral catheter was damaged during the suprapubic puncture. Mild gross haematuria occurred in 15.4% (n = 4) of the cases during the first two hours after SPC placement. Patients' statement of pain during and 2 hours after surgery yielded mean VAS scores of 2.3 (±1.1) and 0.3 (±0.5) respectively. Concerning the question of how inconvenient the procedure was in comparison to their preoperative expectation, 73.0% (n = 19) of patients claimed that the placement of the SPC was more tolerable or even distinctively more tolerable than anticipated. Figure 2 illustrates the outcome of the survey among the 15 physicians. The majority of physicians felt safe when placing the SPC with Suprapur in the high-risk patients. Even more obvious was the result when physicians were also be given preference over TUC in patients suffering from prostatitis with significant post-voiding residual urine [12] . For indwelling catheterization, for instance in patients with neurogenic bladder outlet dysfunction due to spinal cord injury, SPC has also been proven to be associated with fewer urethral and scrotal complications and urinary infections than TUC [13] . Similar results were found for perioperative bladder drainage [14] . Despite its high acceptance and prevalence, SPC harbours some drawbacks especially in terms of possible complications during its placement. There has been little published regarding the safety of SPC insertion, but it is generally seen as a safe and easy procedure that can be performed under local anaesthesia in the outpatient setting [2] . However, SPC placement carries a not insignificant risk of perioperative complications that often offset their advantages over TUC [13] . These are indeed often minor, such as haeasked to compare Suprapur® to conventional punch trocar SPC sets. Almost all (93.3%, n = 14) claimed to feel safer using Suprapur ® in the respective patient. Concerning the level of complexity the results were not as distinct. However, there was still a clear trend towards the statement that Suprapur ® was easier to use than conventional sets. The downside was the fact that the procedure was experienced to be more time consuming by the operating physicians.
DISCUSSION
SPC is a common and frequently performed procedure. It can be applied to treat acute urinary retention when transurethral access is obstructed. Some studies even regard SPC superior to TUC, by reducing the risk of urethral strictures when treating urinary retention due to BPH or performing transurethral resection of the prostate [10, 11] . SPC should technique was largely seen as a safe procedure. It was found to be more convenient and easier to perform than the conventional technique. Most physicians felt more assured with Suprapur ® than with a punch trocar cystostomy set. However, using Suprapur was also stated to be more time consuming, which doubtfully carries much weight with respect to operation times of approximately only 10 minutes. SPC placement is often performed in emergency situations and by physicians with less experience. In our study, 40% of the performing surgeons were either 1 st or 2 nd year residents. Admittedly, surgery was performed under the supervision of a senior physician, but, nevertheless, even in inexperienced hands, Suprapur ® allowed for safe SPC insertion. Generally, SPC offers high patient satisfaction [6, 7] . In our study, SPC placement was experienced as less inconvenient than initially expected by the majority of the patients. Most cases were performed under local anaesthesia and patients stated very low pain levels during and after the procedure. Since different techniques of SPC placements often require analgosedation or general anaesthesia [5, 6, 7] , in this regard, Suprapur ® permits indulgent SPC insertion. There are several important limitations to our study. First and foremost, our study population is composed of a relatively small number of patients. However, the patients were carefully selected, forming a relevant high-risk population. Furthermore, this study makes no comparison to conventional SCP placement in terms of a randomized controlled trial. The comparison to standard SPC insertion has been conducted by customized questionnaires. Finally, there has been insufficient follow-up with regard to relevant long-term complications. Nevertheless, our work consists of a prospective series with carefully selected patients and constitutes a profound evaluation of the Suprapur ® cystostomy set.
CONCLUSIONS
Placement of SPC is a common procedure in everyday medicine. Insertion of the catheter by Seldinger's technique using the Suprapur cystostomy set allows a safe and convenient procedure without considerable complications, even in high-risk patients and in inexperienced hands. As such, it may be a valuable alternative to conventional sets in selected patients.
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We are grateful to Uromed (Oststeinbek, Germany) for providing the Suprapur ® cystostomy sets. maturia or catheter displacement, but may also lead to severe complications such as bowel perforation or even death [6, 7] . Haematuria or SPC exit site bleeding are common problems within the first hours following SPC insertion. In our study, mild haematuria occurred in 15.4% (n = 4) of cases, with no exit site bleeding reported. Although our population contained patients with platelet inhibition due to intake of acetylsalicylic acid, bleeding occurred less commonly than in other studies [15] . Suprapur ® allows placement of a SPC by Seldinger's technique. The puncture cannula is notably smaller than in conventional sets (17.5 GA vs. 10 GA). Hence the likelihood of vessel injury is smaller, although guide wire irrigation may lead to vesical mucosa bleeding. Reducing the risk of bleeding is also a concern in respect of an increasing proportion of patients on anticoagulant therapy, such as aspirin [16] . The use of a guide wire in the insertion of a SPC certainly leads to a safer procedure, in terms of catheter misplacement, a technical complication that was not observed in this study. After bladder puncture with trocar cystostomies, urine efflux may result in bladder decompression and possible cannula displacement, which was previously observed in 3% of the cases [5, 6] . A guide wire on the other hand may help to secure the initial access to the bladder. Our study population presented with risk factors that made SPC insertion more difficult. A high BMI leads to unfavourable conditions for ultrasound guidance due to sound wave scattering in subcutaneous fat [17] . Furthermore, a small bladder capacity, below 300 ml, was shown to significantly increase the rate of complications during SPC insertion [18] . Previous abdominal surgery leads to abdominal wall adhesions in almost 60% of cases and consequently might increase the risk of bowl perforation during SPC placement [19] . In our population the average BMI was 28.8 kg/m 2 and the mean maximum bladder capacity was 210 ml. More than 40% of the patients had previous abdominal surgery. Despite the adverse patient characteristics, we did not observe any complications except for mild gross haematuria. Two larger series on SPC placement under cystoscopic guidance reported a complication rate of more than 10% with around 2.5% blown injuries and a mortality rate of 1.8% respectively 0.8% [6, 7] . Admittedly, we examined fewer cases, but adversely selected patients in terms of risk factors. Since virtually no complications were observed, one may assume that applying Seldinger's technique for SPC placement with the Suprapur ® set allows a generally safe procedure. Accordingly, the survey of the operating physicians showed that SPC placement by Seldinger's
